Home › Squamous Cell Carcinoma › Illinois › Chicago
Squamous Cell Carcinoma clinical trials in Chicago, IL
3 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
RecruitingPhase 2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- University of Illinois Cancer Center, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RecruitingPhase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- New York City, NY7 studies
- Nashville, TN7 studies
- Houston, TX7 studies
- Atlanta, GA5 studies
- Queens, NY4 studies
- Durham, NC4 studies
- Arlington, VA4 studies
- Washington, DC4 studies
- Dallas, TX4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Prostate Cancer45 studies
- Metastatic Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer37 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.